Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,405.20
(
-2.38%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
107.75
(
-0.46%
)
Bitcoin
67,393.95
(
2.18%
)
News Focus
News Focus
Post# of 257302
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122817
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Fred Kadiddlehopper post# 216473

Tuesday, 01/09/2018 1:57:24 PM

Tuesday, January 09, 2018 1:57:24 PM

Post# of 257302
(RVNC/Evolus)—Botulinum toxin from Korea might be a scary thought. However, for the sake of discussion, let’s assume that Evolus manages to obtain FDA approval of DWP-415’s Korean manufacturing facilities as well as the other modules of the pending BLA. Even then, I wonder if the marketing of DWP-415 would be impaired to some degree on account of where the stuff comes from.

The PDUFA date for the DWP-415 BLA is 5/15/18.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today